{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:01:23Z","timestamp":1769266883480,"version":"3.49.0"},"reference-count":26,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background: <\/jats:title>\n<jats:p>Radiogenomics, the intersection of imaging and genetics, is important in improving glioma diagnosis and treatment. This study aims to correlate imaging features with isocitrate dehydrogenase (IDH) mutation status, providing a non-invasive diagnostic tool to identify the genetic background of gliomas.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Methods: <\/jats:title>\n<jats:p>In a retrospective sample of 59 patients with either IDH wild-type (WT) or IDH mutant gliomas, the study employed volumetric and morphologic magnetic resonance imaging (MRI) analyses to discern molecular alterations based on radiographic signatures. Key imaging biomarkers, such as the T2\/fluid-attenuated inversion recovery mismatch, contrast enhancement patterns, and diffusion\/perfusion metrics, were evaluated for their ability to differentiate between IDH-WT and mutant gliomas. Receiver operating characteristic curves were employed to evaluate diagnostic performance, and a logistic regression model was developed for patient classification based on imaging.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Results: <\/jats:title>\n<jats:p>The results revealed that IDH mutant gliomas frequently exhibited distinct imaging characteristics, such as homogenous hyperintense T2 signals and absence of contrast enhancement. In addition, perfusion and diffusion metrics varied significantly between the IDH-WT and mutant groups, offering potential radiogenomic markers. A logistic regression model was developed to predict IDH status with high accuracy, identifying factors such as tumor enhancement size, presence of central necrosis, peritumoral edema, and patient age.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>The study\u2019s results affirm the significance of radiogenomic correlations in predicting IDH status, resonating findings from prior research. We highlight the necessity of a multimodal approach in MRI analysis to enhance the non-invasive diagnostic accuracy for glioma patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_323_2025","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T07:12:00Z","timestamp":1750403520000},"page":"256","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the predictability of isocitrate dehydrogenase mutational status in glioma patients using imaging features"],"prefix":"10.25259","volume":"16","author":[{"given":"Joao Meira","family":"Goncalves","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, S\u00e3o Jo\u00e3o University Hospital, Porto, Portugal"},{"name":"Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Andr\u00e9","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Gaia University Hospital, Rua Concei\u00e7\u00e3o Fernandes, Vila Nova de Gaia, Portugal"}]},{"given":"Carolina","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, S\u00e3o Jo\u00e3o University Hospital, Porto, Portugal"},{"name":"Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Bruno","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, S\u00e3o Jo\u00e3o University Hospital, Porto, Portugal"},{"name":"Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Patricia","family":"Pol\u00f3nia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, S\u00e3o Jo\u00e3o University Hospital, Porto, Portugal"},{"name":"Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Paulo","family":"Linhares","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, S\u00e3o Jo\u00e3o University Hospital, Porto, Portugal"},{"name":"Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]}],"member":"10894","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"10.25259\/SNI_323_2025\/ref-1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3174\/ajnr.A7297","article-title":"Evolving role and translation of radiomics and radiogenomics in adult and pediatric neuro-oncology","volume":"43","author":"Ak","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.25259\/SNI_323_2025\/ref-2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mrm.22445","article-title":"Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter-and intrapatient comparisons","volume":"64","author":"Bedekar","year":"2010","journal-title":"Magn Reson Med"},{"key":"10.25259\/SNI_323_2025\/ref-3","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/noajnl\/vdaa148","article-title":"Introduction to radiomics and radiogenomics in neuro-oncology: Implications and challenges","volume":"2","author":"Beig","year":"2021","journal-title":"Neuro Oncol Adv"},{"key":"10.25259\/SNI_323_2025\/ref-4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-013-0345-4","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"13","author":"Cohen","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.25259\/SNI_323_2025\/ref-5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11060-020-03539-z","article-title":"Molecular characteristics and clinical features of multifocal glioblastoma","volume":"148","author":"Dono","year":"2020","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_323_2025\/ref-6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3892\/ijo.2015.2891","article-title":"Diffusion MRI quality control and functional diffusion map results in ACRIN 6677\/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma","volume":"46","author":"Ellingson","year":"2015","journal-title":"Int J Oncol"},{"key":"10.25259\/SNI_323_2025\/ref-7","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.3390\/cancers13184532","article-title":"Multi-platform classification of IDH-Wild-type glioblastoma based on ERK\/MAPK pathway: Diagnostic, prognostic and therapeutic implications","volume":"13","author":"Georgescu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.25259\/SNI_323_2025\/ref-8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/biomedicines12102327","article-title":"Survival determinants in glioblastoma: An insight into biopsy-only patient outcomes","volume":"12","author":"Gon\u00e7alves","year":"2024","journal-title":"Biomedicines"},{"key":"10.25259\/SNI_323_2025\/ref-9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/brainsci10110874","article-title":"The role of the T2-FLAIR mismatch sign as an imaging marker of idh status in a mixed population of low-and high-grade gliomas","volume":"10","author":"Kapsalaki","year":"2020","journal-title":"Brain Sci"},{"key":"10.25259\/SNI_323_2025\/ref-10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1148\/radiol.2016161382","article-title":"Radiogenomics of glioblastoma: Machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features","volume":"281","author":"Kickingereder","year":"2016","journal-title":"Radiology"},{"key":"10.25259\/SNI_323_2025\/ref-11","doi-asserted-by":"crossref","first-page":"16238","DOI":"10.1038\/srep16238","article-title":"IDH mutation status is associated with a distinct hypoxia\/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma","volume":"5","author":"Kickingereder","year":"2015","journal-title":"Sci Rep"},{"key":"10.25259\/SNI_323_2025\/ref-12","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1016\/j.wneu.2018.10.151","article-title":"Apparent diffusion coefficient as a predictive biomarker for survival in patients with treatment-naive glioblastoma using quantitative multiparametric magnetic resonance profiling","volume":"122","author":"Kim","year":"2019","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_323_2025\/ref-13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.37549\/AR2093","article-title":"The basics of diffusion and perfusion imaging in brain tumors","volume":"43","author":"Korfiatis","year":"2014","journal-title":"Appl Radiol"},{"key":"10.25259\/SNI_323_2025\/ref-14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.25259\/SNI_323_2025\/ref-15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_323_2025\/ref-16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.hoc.2021.08.008","article-title":"Isocitrate dehydrogenase mutant grade II and III glial neoplasms","volume":"36","author":"Mellinghoff","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.25259\/SNI_323_2025\/ref-17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/neuonc\/noaa094","article-title":"Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas","volume":"22","author":"Olson","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_323_2025\/ref-18","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1007\/s00330-020-07467-4","article-title":"The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p\/19qnoncodeleted lower-grade gliomas: A systematic review and diagnostic meta-analysis","volume":"31","author":"Park","year":"2021","journal-title":"Eur Radiol"},{"key":"10.25259\/SNI_323_2025\/ref-19","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","article-title":"T2-FLAIR mismatch, an imaging biomarker for IDH and 1p\/19q status in lower-grade gliomas: A TCGA\/TCIA project","volume":"23","author":"Patel","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.25259\/SNI_323_2025\/ref-20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00330-022-09195-3","article-title":"Editorial comment: Radiogenomics of glioblastoma: Shifting the focus from tumor cells to immune microenvironment","volume":"33","author":"Politi","year":"2023","journal-title":"Eur Radiol"},{"key":"10.25259\/SNI_323_2025\/ref-21","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.3390\/ijms21218004","article-title":"MRI radiomic features to predict IDH1 mutation status in gliomas: A machine learning approach using gradient tree boosting","volume":"21","author":"Sakai","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.25259\/SNI_323_2025\/ref-22","first-page":"20210070","article-title":"Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors","volume":"5","author":"Thomas","year":"2023","journal-title":"BJR Open"},{"key":"10.25259\/SNI_323_2025\/ref-23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.25259\/SNI_323_2025\/ref-24","doi-asserted-by":"crossref","first-page":"e6333","DOI":"10.1097\/MD.0000000000006333","article-title":"The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis","volume":"96","author":"Wan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.25259\/SNI_323_2025\/ref-25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12957-015-0496-7","article-title":"Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma","volume":"13","author":"Wu","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.25259\/SNI_323_2025\/ref-26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/neuonc\/now121","article-title":"Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas","volume":"19","author":"Zhang","year":"2017","journal-title":"Neuro Oncol"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/assessing-the-predictability-of-isocitrate-dehydrogenase-mutational-status-in-glioma-patients-using-imaging-features\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/assessing-the-predictability-of-isocitrate-dehydrogenase-mutational-status-in-glioma-patients-using-imaging-features\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T07:12:03Z","timestamp":1750403523000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/assessing-the-predictability-of-isocitrate-dehydrogenase-mutational-status-in-glioma-patients-using-imaging-features\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":26,"alternative-id":["10.25259\/SNI_323_2025"],"URL":"https:\/\/doi.org\/10.25259\/sni_323_2025","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"256"}}